Targeting Wild-Type and Mutationally Activated FGFR4 in Rhabdomyosarcoma with the Inhibitor Ponatinib (AP24534).
| Autor: | Li, Samuel Q.1, Cheuk, Adam T.1, Shern, Jack F.1, Song, Young K.1, Hurd, Laura1, Liao, Hongling1, Wei, Jun S.1, Khan, Javed1 khanjav@mail.nih.gov |
|---|---|
| Zdroj: | PLoS ONE. Oct2013, Vol. 8 Issue 10, p1-9. 9p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|